Athelas Stock
Athelas is a healthcare technology company that provides an integrated platform designed to modernize medical billing, enhance patient care, and streamline healthcare operations. The company focuses on automating workflows and leveraging artificial intelligence to improve efficiency in healthcare settings.
Sign up for SecondMarket™ to view the market and buy or sell Athelas Stock
Buy + SellAthelas Funding
Sign up to gain insights into Athelas funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the DataDate | Financing Round | Amount | Price per share* | Valuation* |
---|---|---|---|---|
Jan 24, 2022 | Series B | 54.39M | ||
Apr 16, 2021 | Series B | 72.00M | ||
Apr 16, 2021 | Series B | 1.52M | ||
Mar 29, 2019 | Series A | 99.23K | ||
Mar 29, 2019 | Series A | 2.05M | ||
Mar 29, 2019 | Series A | 3.19M | ||
Mar 29, 2019 | Series A | 99.99K | ||
Mar 29, 2019 | Series A | 14.00M | ||
Mar 29, 2019 | Series A | 120.00K |
See Athelas Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Athelas Stock Valuation + Share Prices
View real-time Tape D™ data on Athelas stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get StartedAthelas Management Team
Chief People Officer
Laura Lucas
Director
Jacob Werner
CEO, Director
Min Liu
Chief Revenue Officer
Martin Mackay
Chief Technology Officer
Dhruv Parthasarathy
Co-founder, CEO, Director
Tanay Tandon
Founder, Director
Deepika Bodapati
Director
Hemant Taneja
Athelas Major Investors
Human Capital
General Catalyst Partners LLC
Y Combinator
Initialized Capital
Tribe Capital
Sequoia Capital
Greenoaks Capital Management